Dov-Val-Dil-OH
* Please be kindly noted products are not for therapeutic use. We do not sell to patients.

Category | Mycotoxins |
Catalog number | BBF-05713 |
CAS | 133120-89-5 |
Molecular Weight | 429.59 |
Molecular Formula | C22H43N3O5 |
Online Inquiry
Capabilities & Facilities
Fermentation Lab
4 R&D and scale-up labs
2 Preparative purification labs
Fermentation Plant
Semi pilot, pilot and industrial plant 4 Manufacturing sites 7 Production lines at pilot scale 100+ Reactors of 30-4000 L; 170+ reactors of 20 KL-30 KL; 24+ reactors of >100 KL 2 Hydrogenation reactors (200 L, 4Mpa and 1000L, 4Mpa)
Product Description
Dov-Val-Dil-OH is an intermediate of dolastoxin, a cytotoxic liner peptide produced by Dolabbella auriclaria which exhibits potent antitumor activity.
- Specification
- Properties
- Price Product List
Related CAS | 133120-90-8 (trifluoroacetic acid) |
Synonyms | (3R,4S,5S)-4-((S)-2-((S)-2-(dimethylamino)-3-methylbutanamido)-N,3-dimethylbutanamido)-3-methoxy-5-methylheptanoic acid; (3R,4S,5S)-3-Methoxy-4-[methyl(N,N-dimethyl-L-Val-L-Val-)amino]-5-methylheptanoic acid |
IUPAC Name | (3R,4S,5S)-4-[[(2S)-2-[[(2S)-2-(dimethylamino)-3-methylbutanoyl]amino]-3-methylbutanoyl]-methylamino]-3-methoxy-5-methylheptanoic acid |
Canonical SMILES | CCC(C)C(C(CC(=O)O)OC)N(C)C(=O)C(C(C)C)NC(=O)C(C(C)C)N(C)C |
InChI | InChI=1S/C22H43N3O5/c1-11-15(6)20(16(30-10)12-17(26)27)25(9)22(29)18(13(2)3)23-21(28)19(14(4)5)24(7)8/h13-16,18-20H,11-12H2,1-10H3,(H,23,28)(H,26,27)/t15-,16+,18-,19-,20-/m0/s1 |
InChI Key | RHYYEUIJXQMEBX-DLRXZHIHSA-N |
Appearance | White Solid |
Antibiotic Activity Spectrum | Neoplastics (Tumor) |
BBF-02800 | DB-2073 | Inquiry |
BBF-05808 | Triptolide | Inquiry |
BBF-05853 | Palbociclib | Inquiry |
BBF-05843 | Bacitracin | Inquiry |
BBF-00693 | Ansamitocin P-3 | Inquiry |
BBF-03794 | Geneticin sulfate | Inquiry |
Bio Calculators
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
